The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.

Yongjie Chen,Lijuan Bai,Pu Zhang,Hua Zhao,Qianxiong Zhou
DOI: https://doi.org/10.3390/molecules26185679
IF: 4.6
2021-01-01
Molecules
Abstract:Photoactivated chemotherapy (PACT) is a novel cancer treatment method that has drawn increasing attention due to its high selectivity and low side effects by spatio-temporal control of irradiation. Compared with photodynamic therapy (PDT), oxygen-independent PACT is more suitable for treating hypoxic tumors. By finely tuning ligand structures and coordination configurations, many Ru(II) complexes can undergo photoinduced ligand dissociation, and the resulting Ru(II) aqua species and/or free ligands may have anticancer activity, showing their potential as PACT agents. In this mini-review, we summarized the progress in Ru(II)-based PACT agents, as well as challenges that researchers in this field still face.
What problem does this paper attempt to address?